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Abstract
Objective To evaluate the role of MRI in diagnosing
acute myocarditis by correlation with immunohistological
parameters.
Methods A total of 131 patients (85 men, 46 women; mean
age, 44.9 years) with suspected acute myocarditis were
examined by MRI. The relative water content of the left
ventricular myocardium as well as relative and late
enhancement was correlated with the immunohistological
results in biopsy specimens.
Results Myocardial inflammation was confirmed by immu-
nohistology in 82 of the 131 patients investigated and ruled
out in 49 patients. The sensitivity, specificity and accuracy
for diagnosing myocarditis in patients with immunohisto-
logically proven disease were 48.8%, 73.8% and 57.3%,
respectively, for relative enhancement, 58.3%, 57.1% and
57.9% for relative water content, and 30.6%, 88.1% and
49.6% for late enhancement. A combination of all three
parameters had 39,3% sensitivity and 91,3% specificity and
62,7% accuracy. Relative enhancement and late enhance-
ment significantly correlated with the presence of myocar-
ditis but relative oedema did not.
Conclusion Relative and late enhancement significantly
correlate with the presence of myocarditis, while there is
no significant correlation for relative oedema. Myocarditis
cannot be reliably diagnosed using any of the three MRI
parameters alone but combinations of parameters will
improve specificity.
Keywords Myocarditis.Relative enhencement.Relative
edema.Late enhancement.Immunhistology
Introduction
Magnetic resonance imaging (MRI) is playing an increasing
role in suspected myocarditis, providing information on
cardiac anatomy and function as well as typical signs of
inflammation. These signs include an increase in tissue
fluid or relative oedema [1–3], increased perfusion and
vascular permeability of the myocardium at rest, reflected
in the relative enhancement at MRI [1, 2, 4–7], and the loss
of muscle cells and replacement with scar tissue, seen as
late enhancement [2, 5, 8–10]. Together, the changes seen
at MRI allow one to diagnose myocarditis and monitor its
course. Nevertheless, our experience and published studies
suggest that the role of MRI in general and the reliability of
the different parameters for diagnosing inflammation are
not well established. Having examined a relatively large
group of patients by MRI for whom immunohistological
findings in biopsy specimens are available to serve as an
accurate indicator of the presence of myocardial inflamma-
tion, we performed a retrospective analysis in an attempt to
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Patients and methods
Patients
The study included 131 patients. There were 85 men and 46
women ranging in age from 21 to 79 years with a mean age
of 44.9±13.2 years.
All patients had a preliminary diagnosis of myocarditis
with a clinical indication for cardiac MRI and myocardial
biopsy for immunohistological examination. The patients
were included in the study only if MRI was performed
within 2 weeks of the onset of clinical symptoms.
Follow-up MRI results were not included in the analysis;
only the first MRI examination was analysed in patients
who underwent serial MRI.
The study group of patients with proven acute myocar-
ditis was defined by the presence of histologically and
immunohistologically proven inflammatory infiltration; all
other patients included served as controls.
Materials and methods
The diagnostic performance of MRI in confirming or ruling
out myocarditis was evaluated by retrospectively analysing
cardiovascular MRI and immunohistology of myocardial
biopsies. We correlated the MRI findings with immunohis-
tology because it is a more sensitive indicator of an
inflammatory process than histological examinations,
which are subject to a high sampling error.
For comparison of the two methods, the three features
used for diagnosing myocarditis by MRI [6]—relative
enhancement, relative water content and late enhancement,
each measured during clinical routine MRI—correlated
with the immunohistological findings in right ventricular
myocardial biopsy specimens. According to the Interna-
tional Society and Federation of Cardiology classification,
immunohistology is the more crucial than histology.
According the Dallas-Classification the diagnosis of a
myokarditis requires a inflammatory infiltration and a
necroses of the myocytes. Additional the Dallas-
Classification distinguish the borderline Myocarditis with
few inflammatory cells and without a necroses of the
myocytes. In our study we considerated the borderline
myocarditis as a myocarditis.
Magnetic resonance imaging
All patients were examined on whole-body MRI with a
field strength of 1.5 Tesla (Genesis Signa, General Electric
Medical Systems, Milwaukee, WI, USA). The examina-
tions were performed with two coils, a volume coil (body
coil) and a surface coil (cardiac coil). Details of the
sequences and techniques used are summarised in Table 1.
Since the body coil has a rather homogeneous signal
reception profile, this coil was used for measuring the
relative signal intensities of myocardium and skeleton
muscle. Thus, the inhomogeneous signal profile of the
cardiac surface coil was avoided.
Table 1 Schedule with details of the sequences and techniques, which are used in this study
Relative enhancement Relative water content Late enhancement
MRI technique FSE (fast spin echo) STIR (short tau inversion recovery) IRGE (inversion recovery gradient echo)
Sequence type T1-weighted spin echo T2-weighted triple inversion recovery T1-weighted inversion recovery gradient echo
Coil Body Body Cardiac
Contrast agent Contrast-enhanced Nonenhanced Contrast-enhanced
Breathing Normal breathing Breath-hold Breath-hold
Triggering Prospective ECG triggering Prospective ECG triggering Prospective ECG triggering
TR (ms) Depending on RR Depending on RR 5.5
TE (ms) 20 64 1.4
IT (ms) 150 140 180–240
ET 32 32 1
Matrix (pixels) 256*256 256*256 256*192
FOV (cm) 38*38 38*38 35*35
SL (mm) 20 20 8
Spacing (mm) 2 2 0
NEX 1 1 2
TR time to repetition, TE time to echo, IT inversion time, ET echotrain, FOV field of view, SL slice thickness, NEX number of excitations
1260 Eur Radiol (2011) 21:1259–1266The analysis was performed in routine clinical fashion
by two diagnostic radiologists in consensus; they each had
extensive experience in cardiac MRI .
Relative enhancement
Relative enhancement [6] was calculated quantitatively from
T1-weighted spin echo images obtained before and after
intravenous administration of 0.1 mmol of gadolinium-based
contrast agent per kg body weight (Magnevist
® Schering,
Germany) with the injection-speed of 2 ml/s. The time
interval between injection and imaging was 15 s. Here,
myocardial signal intensities were calculated from five
unenhanced axial slices and the corresponding five postcon-
trast slices. Two regions of interest (ROIs) were defined on
unenhanced images: one ROI encompassing the left ventric-
ular myocardium and another ROI in the musculus erector
spinae (Fig. 1). The ROIs defined on the precontrast images
were transferred 1:1 to the postcontrast images to ensure
measurement of signal intensities in identical myocardial and
skeletal muscle regions for calculation of relative enhance-
ment. The resulting measurement values correspond to the
signal intensities of the respective tissues modulated by
differences in contrast medium uptake. Next, absolute
enhancement was calculated for myocardium and skeletal
muscle using the following formula:
absolute enhancement of the myocardial muscle ¼
SI myocardial muscle with contrast   SI myocardial muscle native
SI myocardial muscle native
absolute enhancement of the skeleton muscle ¼
SI the skeleton muscle with contrast   SI the skeleton muscle native
SI l skeleton muscle native
Finally, relative enhancement was calculated from
absolute enhancement in cardiac and skeletal muscle as
follows:
relative enhancement ¼
absolute enhancement of the myocardial muscle
absolute enhancement of the skeleton muscle
Relative enhancement was calculated as the mean of the
relative enhancements of all five slices. Based on current
study data, the cut-off value for abnormal relative enhance-
ment is 4.
Relative water content
While relative enhancement is determined from axial
images of the heart, we quantified the relative water content
[6] or relative myocardial oedema ratio using three short-
axis slices perpendicular to the interventricular septum
acquired with a fat-saturated T2-weighted triple-inversion
recovery sequence. A circular ROI was defined encompass-
ing the left ventricular myocardium in all three planes.
Signal intensity of skeletal muscle was measured in the
musculus erector spinae (Fig. 2). Drawing the ROI in
skeletal muscle is limited by poor demarcation of the
muscle from adjacent tissue on fat-saturated T2-weighted
images; therefore, we used furthermore a T1-weighted
sequence without fat supression in the same orientation to
improve visualisation of the myocardium and skeletal
muscle. The ROIs were transferred 1 : 1 to the
corresponding T2-weighted sequences, allowing measure-
ment of signal intensities in the anatomically correct
positions. The measured signal intensities were used to
calculate relative water content as follows:
relative water content ¼
signal intensity of the myocardial muscle
signal intensity of the skeleton muscle
Ameanvalueofrelativewatercontentwascalculatedfrom
thevaluescalculatedforeachofthethreeplanes.Basedonthe
results of earlier studies, relative water content <2 is
considerednormal,while valuesof2 orgreater are considered
to indicate suspect findings.
Late enhancement
A contrast-enhanced T1-weighted inversion recovery
gradient echo sequence was used to evaluate late
enhancement [6]. Four-chamber, three-chamber and two-
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ventricle were obtained to determine late enhancement.
Images were acquired 20 min after contrast medium
administration to capture persisting late enhancement,
which is of interest here. Positive late enhancement is
characterised by an area of increased signal intensity
(hyperintensity). That parameter was analyzed visually
and not quantitatively (Fig. 3).
Statistical analysis
Dichotomous or non-metrical data were statistically ana-
lysed using the Chi-squared test according to Pearson, and
results were verified using Fisher’s exact test. In addition,
logistic regression was used to identify correlations and
calculate odds ratios predicting the likelihood of a variable
affecting the result.
Metric results for relative enhancement and relative
water content were presented in box-plot diagrams.
Results
Immunohistology confirmed myocardial inflammation in
82 of the 131 patients examined and excluded disease in 49
patients. The statistical results are summarised in Table 2.
Relative enhancement
There was a significant correlation between relative
enhancement and immunohistological proof of myocarditis
with p=0.016 (Pearson’s Chi-squared test) or p=0.02
(Fisher’s exact test). Mean relative enhancement was 4.4
with a standard deviation of ±2.17 for the subgroup of
patients with proven myocarditis and 3.78 with a standard
deviation of ± 2.68 for those without proven disease
(Fig. 4).
Relative water content
Our analysis revealed no significant correlation between
relative water content and myocarditis. The results of the
statistical analysis are presented in Table 2 and Fig. 5.W e
Fig. 3 Short-axis view of the left ventricle obtained 10 min after
administration of contrast medium. There is an area of suspect
subepicardial focal hyperintensity encircled by a yellow line
Fig. 2 Short-axis view perpendicular to the interventricular septum.
The ROIs are outlined. Here, the pectoralis major muscle is used as
reference. In this case we have measured a relative edema with the
value: 2,4
Fig. 1 Two axial slices before (top) and after (bottom) contrast
medium administration. The yellow lines encircle typical ROIs used in
our study. The latissimus dorsi muscle was used as reference
1262 Eur Radiol (2011) 21:1259–1266calculated the following values: p=0.101 (Pearson’s Chi-
squared test) and p=0.13 (Fisher’s exact test). Mean values
and standard deviations were 2.02±0.34 for patients with
myocarditis and 1.99±0.48 for patients without immuno-
histologically proven myocarditis.
Late enhancement
Our results show a significant correlation between late
enhancement and myocarditis with the following values:
p=0.021 (Pearson’s Chi-squared test) and p=0.027
(Fisher’s exact test). The results are summarised in Table 2.
In addition, the three parameters were evaluated in
combination. In the logistic regression analysis, myocarditis
was defined as a positive immunohistological test or a
borderline positive test.
All parameters investigated showed significant differ-
ences (p=0.05). The odds ratios for relative enhancement
and late enhancement were 2.4 and 2.8, respectively, for the
presence of myocarditis versus absence of myocarditis.
The sensitivity, specificity and accuracy calculated for
the use of all three parameters—relative oedema, relative
enhancement and late enhancement—were 39,3%, 91,3%
and 62,7% respectively.
The results demonstrated significant differences with
values of p=0.013 (Pearson’s Chi-squared test) and
p=0.022 (Fisher’s exact test), which are below the assumed
level of significance of p=0.05.
Discussion
Relative enhancement
The relative enhancement was calculated quantitatively from
T1-weighted spin echo images obtained before and after
intravenous administration of 0.1 mmol of gadolinium-based
contrast agent per kg body weight (Magnevist
® Schering,
Germany) with the injection-speed of 2 ml/s. The time
interval between injection and imaging was 15 s. Here,
myocardial signal intensities were calculated from five
Fig. 4 Relative enhancement in the relationship with the results of
immunohistology. Box-plot diagram illustrating the distribution of
relative enhancement values in patients with negative immunohistol-
ogy for myocarditis and those positive for the disease (including
borderline myocarditis)
Table 2 Comparison of our results with those oft wo recently published studies
Results of present study Gutberlet et al. Radiology
2008 (9)
Abdel- Aty et al. J Am Coll
Cardiol 2005 (3)
Relative enhancement Sensitivity (%) 48.8 63 80
Specificity (%) 73.8 86 68
Positive predictive value (%) 78.4 86 74
Negative predictive value (%) 42.5 63 75
Accuracy (%) 57.3 72 74
Relative water content Sensitivity (%) 58.3 67 84
Specificity (%) 57.1 69 74
Positive predictive value (%) 73.1 74 78
Negative predictive value (%) 40.7 60 81
Accuracy (%) 57.9 67 79
Late enhancement Sensitivity (%) 30.6 27 44
Specificity (%) 88.1 80 100
Positive predictive value (%) 83.9 65 78
Negative predictive value (%) 38.5 44 62
Accuracy (%) 49.6 49 71
Eur Radiol (2011) 21:1259–1266 1263unenhanced axial slices and the corresponding five postcon-
trast slices. Two regions of interest (ROIs) were defined on
unenhanced images: one ROI encompassing the left ventric-
ular myocardium and another ROI in the musculus erector
spinae
Since the body coil has a rather homogeneous signal
reception profile, this coil was used for measuring the
relative signal intensities of myocardium and skeleton
muscle. Thus, the inhomogeneous signal profile of the
cardiac surface coil was avoided.
In our study, relative enhancement has a sensitivity of
only 48.8% for detecting immunohistologically proven
acute myocarditis, which is low compared with data
reported in the literature These results suggest that relative
enhancement alone is not a reliable diagnostic criterion or
screening test for acute myocarditis [1, 2]. The negative
predictive value and accuracy are also low at 42.5% and
42.5%, respectively. On the other hand, specificity and
positive predictive value are relatively high (73.8% and
78.4%, respectively) and similar to the values reported from
comparable studies. Higher values were found by Gutberlet
et al. [2]. One can only speculate why our results are
poorer. One possible explanation is the difference in the
number of patients examined: 131 in our study versus 83 in
the study by Gutberlet et al. and 47 in the study by Abdel-
Aty et al. [1]. These differences might lead to greater
variance in the data and hence affect the results. The
discrepancy may also be due to the fact that Gutberlet et al.
only investigated patients with chronic myocarditis. It is
conceivable that myocardial inflammation starting out as a
focal lesion may extend throughout the myocardium as the
condition becomes chronic. This assumption is confirmed
by the results reported by Laissy et al. showing focal
enhancement within the first 7 days after the onset of
symptoms and diffuse relative enhancement further along
the course [7]. As our patients were examined at the acute
stage within 2 weeks of the onset of clinical symptoms, it is
conceivable that the signal enhancement in an early focus
of myocardial inflammation is compensated for by the
normal signal intensity of surrounding healthy myocardial
tissue. This is because we calculated a mean value of
relative enhancement from the signal intensities measured
throughout the myocardium visible on the respective
images. This method may lead to a normal MRI result in
patients with immunohistologically proven myocarditis. A
third possible explanation is that different patient selection
criteria were used, which might in particular explain the
difference in results between our study and that of Abdel-
Aty et al., who examined patients who potentially had
myocarditis and completely healthy volunteers without
symptoms. On the other hand, our entire study population
consisted of individuals with a high clinical suspicion of
acute myocarditis. As a result, our controls were patients
who were immunohistologically negative for acute myo-
carditis. This means that we had no definitive evidence for
the absence of myocarditis in the control patients as
immunohistology has low sensitivity because of a
relatively high sampling error of endomyocardial biopsy,
which may explain the relatively moderate sensitivity of
relative enhancement in our study. It is of note that in the
study of Abdel-Aty et al. myocardial biopsies were
obtained in only two patients, which might also have
distorted the results because no gold standard diagnosis
was available for most of the patients and definitive
proof of myocarditis was not available for the patients
with relative enhancement at MR [1].
In our study, the group of patients with immunohisto-
logically proven myocarditis had a mean relative enhance-
ment of 4.4 with a standard deviation of ±2.17 versus
3.78±2.68 in the patients with negative immunohistology;
the difference between the two groups is not significant.
These values are comparable to those found by Gutberlet
et al., whereas Abdel-Aty et al. reported a mean relative
enhancement in diseased patients of 6.8 with a standard
deviation of ±4.0. The difference may be due to the small
number of cases examined by Abdel-Aty et al. or the fact
that they examined asymptomatic healthy individuals as
controls. The latter point alone does not explain the higher
mean value of relative enhancement as such but the
examination of asymptomatic patients as controls might
explain the clearer separation of the two groups in the
study of Abdel-Aty et al. compared with a control group
consisting of symptomatic patients with suspected myo-
carditis in our study.
Fig. 5 Relative water content in the relation with the results of
immunohistology. Box-plot diagram illustrating the distribution of
relative water content in patients with negative immunohistology for
myocarditis and those positive for the disease (including borderline
myocarditis)
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revealed no significant correlation between relative en-
hancement and myocarditis with p=0.188. The odds ratio is
2.4; in other words, there is a 2.4-fold higher chance of
relative enhancement being positive in patients with
myocarditis versus patients without myocarditis. This is
not a hard indicator but is meaningful as a clue in
conjunction with other findings. In conclusion, relative
enhancement alone is not a sufficient diagnostic parameter
for myocarditis, and our results in acute myocarditis are
even poorer than published data on chronic myocarditis [7].
Nevertheless, relative enhancement is useful as one of
several criteria in diagnosing myocarditis.
Relative water content
The relative water content we found in our patients with
proven myocarditis is below that reported by other
authors [1, 2]. Again, the discrepancies may be due to
the problems outlined above (different numbers of
patients, selection criteria, lack of proof of disease by
endomyocardial biopsy); in addition, general problems
associated with the measurement of water content may
play a role. When there is oedema, the fluid content of
tissue is increased. Most of the fluid comes from the blood
vessels. Extravasation may be caused by inflammatory
processes in the setting of myocarditis or might be due to
inflammatory or destructive vasculopathies. Examples of
vessel diseases include vasculitis or microangiopathy in
diabetes mellitus. The results are also influenced by the
fact that relative water content is calculated in relation to
that of skeletal muscle. If there is additional oedema of
the skeletal muscle of whatever aetiology, the MRI result
for relative water content will be pseudonormal. Inves-
tigating the distribution of relative enhancement in
myocardium and skeletal muscle in patients with myo-
carditis, Laissy et al. found increased enhancement of
both the myocardium and peripheral skeletal muscle
within the first 7 days after onset of symptoms,
suggesting that there is either systemic inflammation or
involvement of skeletal muscle [7]. This might also hold
true for relative oedema.
In summary, relative water content alone is even less
suitable for diagnosing myocarditis compared with relative
enhancement. Relative water content may be interpreted as
a clue pointing to the disease but, based on our results, this
parameter does not allow more concrete diagnostic con-
clusions to be drawn.
Late enhancement
Late enhancement is the only one of the three MRI
parameters for which we found a comparable or even
higher statistical significance compared with the study of
chronic myocarditis by Gutberlet et al. However, our
results are again poorer than those reported by Abdel-Aty
et al. Late enhancement has a high specificity compared
with relative enhancement and relative water content,
while sensitivity is low, rendering this parameter superior
to the other two MRI criteria for confirming suspected
disease with the low sensitivity precluding the use of this
parameter for detecting myocarditis, e.g. in a screening
test.
There are several possible explanations for the low
sensitivity of late enhancement. Late enhancement, or
the persistence of contrast agent in the interstitial space,
occurs not only during acute inflammation but also
when there is remodelling during healing or may reflect
scar tissue or fibrosis as late sequelae of acute
myocarditis [11]. It is conceivable that, despite symp-
tomatic disease, the immunohistological examination
may be positive before an organised focus of inflamma-
tion becomes morphologically apparent or before there is
myocyte loss with subsequent scar formation or fibrosis,
conditions that are associated with contrast medium
extravasation into the interstitial space seen as late
enhancement on MR images. Hence, it can be assumed
that cell loss has not yet occurred in acute myocarditis
and there is no necrosis or scar tissue to produce late
enhancement. Late enhancement significantly correlates
with immunohistologically proven myocarditis in our
study (p=0.021 or p=0.027). The odds ratio of approx.
2.8 suggests that the probability of seeing late enhance-
ment in patients with myocarditis has the highest
probability of all three MRI criteria investigated. Never-
theless, late enhancement alone does not provide a
reliable diagnostic criterion for myocarditis.
Combining all three MRI parameters, a positive result
for one of the three was found to have a sensitivity of
39,3% with the highest specificity of 91.3% being observed
when all three criteria were positive.
Our results suggest that all MRI criteria should be used
in combination to arrive at a well-founded conclusion
regarding the presence of myocarditis, which is notoriously
difficult to diagnose. A positive MRI result may thus serve
as a basis for ordering further diagnostic tests. If all three
MRI parameters are positive in a patient with the classical
clinical symptoms, a diagnosis of myocarditis can be made
with a high degree of specificity.
Limitations
In our study, endomyocardial biopsy specimens were
sampled from different septal regions although some earlier
publications already recommended targeted biopsy from
potential sites of inflammation suggested by late enhance-
Eur Radiol (2011) 21:1259–1266 1265ment on MR images [5, 12]. Non-targeted biopsy increases
the sampling error, resulting in lower sensitivity [13]. Our
biopsy technique may have distorted the MRI results as the
immunohistological examination defined the group of
patients with myocarditis in our study. The second problem
directly following from this procedure is that we classified
borderline myocarditis as positive for myocarditis. This
milder form of disease may lead to less pronounced
changes in the MRI parameters investigated, which also
affects our results.
Although we investigated a larger number of patients
than both Gutberlet et al. and Abdel-Aty et al., the study
is still too small to obtain truly representative statistical
data. This is suggested by the measure of quality of
logistic regression, the Nagelkerke’s R-square, which is
0.127 and thus well below the maximum possible value
of nearly 1.
While MRI is quite accurate, shown both in our study and
the most important studies [14] reported in the literature, it
should not be used alone to diagnose myocarditis. The final
conclusion to be drawn from the results presented here is that
all parameters that can be derived from cardiovascular
magnetic resonance imaging taken together allow good
non-invasive diagnosis of myocarditis with high specificity
but have to be supplemented by additional tests for adequate
diagnostic management of myocarditis.
Conclusion
The three parameters used for diagnosing acute myocar-
ditis by MRI—relative oedema, relative enhancement and
late enhancement—in part correlate significantly with the
presence of myocarditis. Nevertheless, none of the three
MRI parameters alone allows one to reliably confirm or
rule out disease. The diagnosis can be made with a much
higher degree of confidence when all three parameters
are used, which specificity. But even the combination of
MRI parameters does not allow detection of all cases of
the disease, which is why the results should always be
interpreted in conjunction with a patient’s clinical
symptoms, the findings of other diagnostic tests, and
not least of all the results of myocardial biopsy.
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